Hematology
c. 5th–4th century BCE — Hippocratic Corpus, Ancient Greece
Purpura, characterized by the appearance of reddish-purple discolorations on the skin resulting from bleeding beneath its surface, attracted the attention of physicians across antiquity, who interpreted its dramatic visual presentation through supernatural, humoral, and later vascular frameworks. The condition's association with serious illness and death gave it a place of particular gravity in historical medical literature. Centuries passed before the relationship between purpura and disorders of blood and blood vessels was properly understood.
Historical Narrative
Ancient observers noted with alarm the appearance of purple and reddish spots on the skin of gravely ill individuals, and references to such phenomena appear in the Hippocratic Corpus dating to the fifth and fourth centuries BCE. Hippocratic writers regarded the sudden eruption of these spots as a prognostic sign of great significance, typically indicating that a patient's condition had reached a critical or terminal stage. The color purple carried symbolic weight in the ancient world, and the appearance of such markings on the skin was invested with meaning that blended medical observation with cultural and even spiritual interpretation.
Galen of Pergamon, working in the second century CE, attempted to explain purpuric lesions within his humoral framework, associating them with an excess or corruption of black bile and with putrefaction of the blood. He noted their association with severe febrile illnesses and considered their appearance an ominous prognostic indicator. Galenic doctrine on this subject persisted through the medieval period, and physicians encountering patients with purpuric lesions generally interpreted what they saw as evidence of profound humoral derangement.
Medieval European and Islamic physicians continued to document purpuric conditions, often in the context of epidemic disease. The catastrophic plague outbreaks of the fourteenth century, during which hemorrhagic manifestations including subcutaneous bleeding were observed in some victims, sharpened medical attention to purpuric phenomena. Physicians of the period, including those working within the scholastic medical tradition at universities such as Paris and Bologna, debated whether such hemorrhagic signs indicated corrupted blood, astrological influence, or miasmatic poisoning from corrupt air.
The sixteenth and seventeenth centuries brought renewed interest in the careful description of clinical phenomena, and several European physicians produced accounts of hemorrhagic skin conditions that modern historians have identified as early descriptions of what later medicine would classify as purpura. Lazaro Riverius, the Italian physician Marcello Malpighi, and others contributed observational records during this era, though mechanistic explanation remained elusive.
A major advance in understanding came in the eighteenth century when Eduard Henoch and Johann Lukas Schönlein, working in nineteenth-century Germany, provided systematic clinical descriptions of a form of purpura accompanied by joint pain and abdominal symptoms. Schönlein first described this constellation in 1837, and Henoch extended the description in the 1870s and 1880s, adding observations about renal involvement in some cases. The condition they described would eventually bear both their names and became one of the first well-characterized clinical syndromes within the broader category of purpuric disorders.
The development of hematology as a scientific discipline in the nineteenth and early twentieth centuries transformed understanding fundamentally. The identification of platelets as distinct blood components — work associated with figures including Giulio Bizzozero in the 1880s — provided a cellular mechanism through which certain forms of purpura could begin to be explained. Bizzozero's description of platelets and their role in hemostasis opened a new explanatory framework. Subsequent decades brought the recognition that purpura could arise through multiple distinct pathways, including platelet deficiency, vascular fragility, and coagulation abnormalities, establishing the heterogeneous nature of what had long been treated as a single phenomenon.
Key Historical Figures
Historical narrative only — this page describes how Purpura was understood historically. It is not medical advice and does not describe current diagnosis or treatment. Sourced from verified medical history references (NIH, Encyclopaedia Britannica, and standard medical history texts). See our medical disclaimer.